Michael Looby
Impact in
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Inflammatory mediators and NSAID effects
Papers in ⓘ
-
- Statistical Methods in Clinical Trials 6
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Willi Weber (5 shared papers)Christian Bartels (2 shared papers)Didier Renard (2 shared papers)Romain Séchaud (1 shared paper)Jürgen Brockmöller (2 shared papers)Joachim Köchling (1 shared paper)H.-H. Neumayer (1 shared paper)Ivar Roots (1 shared paper)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (3 papers)The Journal of Clinical Pharmacology (2 papers)British Journal of Clinical Pharmacology (2 papers)Clinical Pharmacokinetics (2 papers)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Michael Looby
22 papers receiving 418 citations
Peers
Comparison fields: 5 of 92
- Pharmacology 121
- Nephrology 34
- Physiology 116
- Pulmonary and Respiratory Medicine 134
- Pharmacology 35
Countries citing papers authored by Michael Looby
This map shows the geographic impact of Michael Looby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Looby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Looby more than expected).
Fields of papers citing papers by Michael Looby
This network shows the impact of papers produced by Michael Looby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Looby. The network helps show where Michael Looby may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Looby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 55 | |
| 2 | The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients. | 1992 | 42 |
| 3 | 2013 | 41 | |
| 4 | 1990 | 37 | |
| 5 | 2011 | 36 | |
| 6 | 1993 | 35 | |
| 7 | 2012 | 30 | |
| 8 | 2010 | 24 | |
| 9 | 1991 | 22 | |
| 10 | 2009 | 21 | |
| 11 | 2009 | 16 | |
| 12 | 2011 | 14 | |
| 13 | 2021 | 10 | |
| 14 | 2018 | 10 | |
| 15 | 1994 | 9 | |
| 16 | 1997 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2015 | 4 | |
| 19 | 1996 | 3 | |
| 20 | 1992 | 3 |
About Michael Looby
Michael Looby is a scholar working on Statistics and Probability, Pharmacology, Transplantation, Pharmacology and Hepatology, having authored 23 papers that have together received 432 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (3 papers), Asthma and respiratory diseases (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). The work is most often cited by research in Pharmacology (121 citations), Nephrology (34 citations), Physiology (116 citations), Pulmonary and Respiratory Medicine (134 citations) and Pharmacology (35 citations). Michael Looby has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Willi Weber, Christian Bartels, Didier Renard, Romain Séchaud, Jürgen Brockmöller, Joachim Köchling, H.-H. Neumayer, Ivar Roots, Donald R. Stanski and Slavica Milosavljev. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Clinical Pharmacokinetics and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.